Skip to main content
Fig. 1 | Allergy, Asthma & Clinical Immunology

Fig. 1

From: Therapeutic effects of intranasal tocotrienol-rich fraction on rhinitis symptoms in platelet-activating factor induced allergic rhinitis

Fig. 1

PAF-induced AR animal model. The rats were intranasally instilled with PAF on day 0 to induce AR. Treatment with TRF in excipient solution or pure excipient solution was administered intranasally to the AR rats from day 1 to 7. No treatment was given to the control rats. All the rats were sacrificed on day 8 and upper skulls were collected for histological examination using H&E. AR, Allergic rhinitis; H&E, Hematoxylin and eosin; PAF, Platelet-activating factor; TRF, Tocotrienol-rich fraction

Back to article page